{"entity":{"type":"insider","cik":"0001798155","url":"/insider/0001798155","json_url":"/insider/0001798155.json","name":"Keutzer Timothy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2023-02-03","last":"2026-02-09","span_basis":"filed_date"},"name_variants":[{"name":"Keutzer Timothy","source":"filing","n_filings":8,"first_seen":"2023-02-03","last_seen":"2026-02-09"}],"transactions":[{"id":5846933,"accession":"0001193125-26-043315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-043315","line_url":"/filing/0001193125-26-043315#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18652.0,"shares_display":"18,652","price_per_share":2.36,"price_display":"2.36","price_state":"stated","total_value":44018.72,"total_display":"44,018.72","total_whole":"44,019","shares_owned_after":742506.0,"shares_owned_after_display":"742,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider"},{"id":6111078,"accession":"0001193125-26-038441","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-038441","line_url":"/filing/0001193125-26-038441#line-4","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3471.0,"shares_display":"3,471","price_per_share":2.24,"price_display":"2.24","price_state":"stated","total_value":7775.04,"total_display":"7,775.04","total_whole":"7,775","shares_owned_after":761158.0,"shares_owned_after_display":"761,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-05","scope":"insider"},{"id":6111075,"accession":"0001193125-26-038441","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-038441","line_url":"/filing/0001193125-26-038441#line-3","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24224.0,"shares_display":"24,224","price_per_share":2.14,"price_display":"2.14","price_state":"stated","total_value":51839.36,"total_display":"51,839.36","total_whole":"51,839","shares_owned_after":764629.0,"shares_owned_after_display":"764,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-05","scope":"insider"},{"id":6111072,"accession":"0001193125-26-038441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-038441","line_url":"/filing/0001193125-26-038441#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18891.0,"shares_display":"18,891","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":41560.2,"total_display":"41,560.20","total_whole":"41,560","shares_owned_after":788853.0,"shares_owned_after_display":"788,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-05","scope":"insider"},{"id":4662675,"accession":"0000950170-25-112659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-112659","line_url":"/filing/0000950170-25-112659#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1695.0,"shares_display":"1,695","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":3339.15,"total_display":"3,339.15","total_whole":"3,339","shares_owned_after":739744.0,"shares_owned_after_display":"739,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-09-03","scope":"insider"},{"id":4263096,"accession":"0000950170-25-014866","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-014866","line_url":"/filing/0000950170-25-014866","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56537.0,"shares_display":"56,537","price_per_share":0.78,"price_display":"0.78","price_state":"stated","total_value":44098.86,"total_display":"44,098.86","total_whole":"44,099","shares_owned_after":766359.0,"shares_owned_after_display":"766,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-05","scope":"insider","n_lines":3},{"id":2037612,"accession":"0000950170-24-101998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-101998","line_url":"/filing/0000950170-24-101998#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2213.0,"shares_display":"2,213","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":2987.55,"total_display":"2,987.55","total_whole":"2,988","shares_owned_after":531837.0,"shares_owned_after_display":"531,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-29","scope":"insider"},{"id":2234855,"accession":"0000950170-24-011501","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-011501","line_url":"/filing/0000950170-24-011501#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30971.0,"shares_display":"30,971","price_per_share":1.36,"price_display":"1.36","price_state":"stated","total_value":42120.56,"total_display":"42,120.56","total_whole":"42,121","shares_owned_after":534050.0,"shares_owned_after_display":"534,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider"},{"id":8250903,"accession":"0000950170-23-045450","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-045450","line_url":"/filing/0000950170-23-045450#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1854.0,"shares_display":"1,854","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":2336.04,"total_display":"2,336.04","total_whole":"2,336","shares_owned_after":325290.0,"shares_owned_after_display":"325,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-28","filed_date":"2023-08-30","scope":"insider"},{"id":8135128,"accession":"0000899243-23-003948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003948","line_url":"/filing/0000899243-23-003948#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001798155","owner_name":"Keutzer Timothy","owner_display_name":"Keutzer Timothy","owner_url":"/insider/0001798155","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3394.0,"shares_display":"3,394","price_per_share":1.86,"price_display":"1.86","price_state":"stated","total_value":6312.84,"total_display":"6,312.84","total_whole":"6,313","shares_owned_after":327144.0,"shares_owned_after_display":"327,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001701108","name":"Spero Therapeutics, Inc.","url":"/issuer/0001701108","role":"Officer (Chief Operating Officer)","n_filings":8,"first_seen":"2023-02-03","last_seen":"2026-02-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001798155","retrieved_at":"2026-08-25T18:46:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}